ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ovarian cancer.
LUNG: 29% | Pulmonx shares are trading higher after the company reported better-than-expected Q1 financial results.
EBS: 83% | Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.